Figure 4
Figure 4. IGH rearrangement analysis shows oligoclonal expansion from LICs and polyclonal expansion from CD34+CD38−CD19−CD33− cells. (A) In MLL-AF4 case 3, PCR for IGH rearrangements showed the presence of a dominant clone present in CD34+ and CD34− cells, regardless of CD33 expression. (B) IGH rearrangement patterns of 4 engrafted cell populations from recipients of CD34+CD38−CD19−CD33+ LICs (left column of panels), CD34−CD19+ LICs (second and third columns of panels), and CD34+CD38−CD19−CD33− cells (right column of panels) isolated from MLL-AF4 case 3. Shared dominant clones were detected in (left) CD34+CD38+CD19+ cells from recipient 1-32 engrafted with CD34+CD38−CD19−CD33+ LICs, and (second from left) CD34+ and (third from left) CD34− cells from recipient 1-18 engrafted with CD34−CD19+ LICs. In contrast, CD19+CD33− B cells in recipient N1-1 engrafted with CD34+CD38−CD19−CD33− cells from MLL-AF4 case 3 (right column) show polyclonal pattern of IGH rearrangement.

IGH rearrangement analysis shows oligoclonal expansion from LICs and polyclonal expansion from CD34+CD38CD19CD33 cells. (A) In MLL-AF4 case 3, PCR for IGH rearrangements showed the presence of a dominant clone present in CD34+ and CD34 cells, regardless of CD33 expression. (B) IGH rearrangement patterns of 4 engrafted cell populations from recipients of CD34+CD38CD19CD33+ LICs (left column of panels), CD34CD19+ LICs (second and third columns of panels), and CD34+CD38CD19CD33 cells (right column of panels) isolated from MLL-AF4 case 3. Shared dominant clones were detected in (left) CD34+CD38+CD19+ cells from recipient 1-32 engrafted with CD34+CD38CD19CD33+ LICs, and (second from left) CD34+ and (third from left) CD34 cells from recipient 1-18 engrafted with CD34CD19+ LICs. In contrast, CD19+CD33 B cells in recipient N1-1 engrafted with CD34+CD38CD19CD33 cells from MLL-AF4 case 3 (right column) show polyclonal pattern of IGH rearrangement.

Close Modal

or Create an Account

Close Modal
Close Modal